<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">seamed</journal-id><journal-title-group><journal-title xml:lang="ru">Морская медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Marine Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2413-5747</issn><issn pub-type="epub">2587-7828</issn><publisher><publisher-name>Research Institute of Industrial and Maritime Medicine of the Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22328/2413-5747-2024-10-3-7-13</article-id><article-id custom-type="elpub" pub-id-type="custom">seamed-699</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Лекции</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Lectures</subject></subj-group></article-categories><title-group><article-title>Интерпретация клинического анализа крови. Часть 2. Тромбоциты</article-title><trans-title-group xml:lang="en"><trans-title>Interpretation of Clinical Blood test. Part 2. Platelets</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0966-9571</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Базарный</surname><given-names>Владимир Викторович</given-names></name><name name-style="western" xml:lang="en"><surname>Bazarnyi</surname><given-names>Vladimir V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, заслуженный деятель науки РФ, главный научный сотрудник отдела общей патологии</p></bio><bio xml:lang="en"><p>Drof Sci. (Med.), Professor, Honored Scientist of the Russian Federation, Chief Researcher of the Department of General Pathology</p></bio><email xlink:type="simple">vlad-bazarny@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5698-8404</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гребнев</surname><given-names>Дмитрий Юрьевич</given-names></name><name name-style="western" xml:lang="en"><surname>Grebnev</surname><given-names>Dmitry Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, доцент, заведующий кафедрой патологической физиологии</p></bio><bio xml:lang="en"><p>Drof Sci. (Med.), Chief the Department of Pathological Physiology</p></bio><email xlink:type="simple">dr-grebnev77@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Уральский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ural State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>09</month><year>2024</year></pub-date><volume>10</volume><issue>3</issue><fpage>7</fpage><lpage>13</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Базарный В.В., Гребнев Д.Ю., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Базарный В.В., Гребнев Д.Ю.</copyright-holder><copyright-holder xml:lang="en">Bazarnyi V.V., Grebnev D.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://seamed.elpub.ru/jour/article/view/699">https://seamed.elpub.ru/jour/article/view/699</self-uri><abstract><p>Современные гематологические анализаторы позволяют дать информативную оценку тромбоцитарных параметров, характеристике которых посвящена данная лекция, являющаяся продолжением цикла лекций по клиническому анализу крови, начатого в 2023 г. Наряду с количеством тромбоцитов рассматриваются средний объем тромбоцитов – MPV (mean platelet volume), ширина распределения тромбоцитов по объему (PDW), доля (%) крупных тромбоцитов – P-LCR (platelet large cell ratio), РСТ – тромбокрит, фракция незрелых тромбоцитов – IPF (Immature Platelet Fraction), средний тромбоцитарный компонент (средняя концентрация компонентов тромбоцитов, МРС – mean platelet component), средняя сухая масса тромбоцитов (MPM), гетерогенность тромбоцитов по данному параметру – PCDW (platelet component distribution width). Несмотря на то что каждый тромбоцитарный параметр имеет определенную клиническую ценность, при возможности стоит оценивать всю их совокупность. В ряде случаев важно оценить морфологию и расположение этих форменных элементов в окрашенном мазке крови.</p></abstract><trans-abstract xml:lang="en"><p>Modern hematology analyzers make it possible to give an informative evaluation of platelet parameters, which characteristic this lecture is devoted to, being the continuation of the lecture series on clinical blood test, started in 2023. Along with platelet count, mean platelet volume (MPV), platelet distribution width (PDW), platelet large cell ratio (%) (P-LCR), platelet crit (РСТ), immature platelet fraction (IPF), mean platelet component (МРС), mean dry platelet mass (MPM), platelet component distribution width (PCDW) are considered. Despite the fact that each platelet parameter has the certain clinical value, the whole combination of them should be evaluated if possible. In some cases, it is important to assess morphology and location of these formed elements in the stained blood smear.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>морская медицина</kwd><kwd>клинический анализ крови</kwd><kwd>тромбоциты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>marine medicine</kwd><kwd>clinical blood test</kwd><kwd>platelets</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Луговская С. А., Почтарь М. Е., Погорелов В. М. Основные исследования в лабораторной гематологии. В кн. Клиническая лабораторная диагностика: национальное руководство. Т.1- С.492-519. [Lugovskaya S. A., Pochtar M. E., Pogorelov V. M. Basic research in laboratory hematology. In the book. Clinical laboratory diagnostics: national guidelines, Vol. 1, pp. 492–519 (In Russ.)].</mixed-citation><mixed-citation xml:lang="en">Луговская С. А., Почтарь М. Е., Погорелов В. М. Основные исследования в лабораторной гематологии. В кн. Клиническая лабораторная диагностика: национальное руководство. Т.1- С.492-519. [Lugovskaya S. A., Pochtar M. E., Pogorelov V. M. Basic research in laboratory hematology. In the book. Clinical laboratory diagnostics: national guidelines, Vol. 1, pp. 492–519 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Benlachgar N, Doghmi K, Masrar A, Mahtat EM, Harmouche H, Tazi Mezalek Z. Immature platelets: a review of the available evidence. Thromb Res. 2020, 195, 43–50. doi: 10.1016/j.thromres.2020.06.048.</mixed-citation><mixed-citation xml:lang="en">Benlachgar N, Doghmi K, Masrar A, Mahtat EM, Harmouche H, Tazi Mezalek Z. Immature platelets: a review of the available evidence. Thromb Res. 2020, 195, 43–50. doi: 10.1016/j.thromres.2020.06.048.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Halawi M. Prognostic Value of Evaluating Platelet Role, Count and Indices in Laboratory Diagnosis of Different Types of Solid Malignancies. Pak J Biol Sci. 2022 Jan;25(2):100-105. doi: 10.3923/pjbs.2022.100.105.</mixed-citation><mixed-citation xml:lang="en">Halawi M. Prognostic Value of Evaluating Platelet Role, Count and Indices in Laboratory Diagnosis of Different Types of Solid Malignancies. Pak J Biol Sci. 2022 Jan;25(2):100-105. doi: 10.3923/pjbs.2022.100.105.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">González-López TJ, Provan D, Bárez A, Bernardo-Gutiérrez A, Bernat S, Martínez-Carballeira D, Jarque-Ramos I, Soto I, Jiménez-Bárcenas R, Fernández-Fuertes F. Primary and secondary immune thrombocytopenia (ITP): Time for a rethink. Blood Rev. 2023 Sep;61:101112. doi: 10.1016/j.blre.2023.101112.</mixed-citation><mixed-citation xml:lang="en">González-López TJ, Provan D, Bárez A, Bernardo-Gutiérrez A, Bernat S, Martínez-Carballeira D, Jarque-Ramos I, Soto I, Jiménez-Bárcenas R, Fernández-Fuertes F. Primary and secondary immune thrombocytopenia (ITP): Time for a rethink. Blood Rev. 2023 Sep;61:101112. doi: 10.1016/j.blre.2023.101112.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kalyoncu D. Platelet indices in overweight and obese children. Eur J Pediatr. 2023 Sep;182(9):3989-3995. doi: 10.1007/s00431-023-05082-1.</mixed-citation><mixed-citation xml:lang="en">Kalyoncu D. Platelet indices in overweight and obese children. Eur J Pediatr. 2023 Sep;182(9):3989-3995. doi: 10.1007/s00431-023-05082-1.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions. Mediators Inflamm, 2019, Vol. 2019, pp. 9213074. doi: 10.1155/2019/9213074.</mixed-citation><mixed-citation xml:lang="en">Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions. Mediators Inflamm, 2019, Vol. 2019, pp. 9213074. doi: 10.1155/2019/9213074.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Wang S, Xiao H, Lu F, Zhang B, Zhou T. Evaluation and validation of the prognostic value of platelet indices in patients with leukemia. Clin Exp Med. 2023 Oct;23(6):1835-1844. doi: 10.1007/s10238-022-00985-z.</mixed-citation><mixed-citation xml:lang="en">Li Y, Wang S, Xiao H, Lu F, Zhang B, Zhou T. Evaluation and validation of the prognostic value of platelet indices in patients with leukemia. Clin Exp Med. 2023 Oct;23(6):1835-1844. doi: 10.1007/s10238-022-00985-z.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Palmer L, Briggs C, McFadden S, Zini G, Burthem J, Rozenberg G, Proytcheva M, Machin SJ. ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features. Int J Lab Hematol. 2015, Vol. 37, № 3, pp.287–303.</mixed-citation><mixed-citation xml:lang="en">Palmer L, Briggs C, McFadden S, Zini G, Burthem J, Rozenberg G, Proytcheva M, Machin SJ. ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features. Int J Lab Hematol. 2015, Vol. 37, № 3, pp.287–303.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
